News

HDA Media And Political Bulletin – 10 March 2016

Pharmaceutical industry’s contribution towards NHS medicines bill hits £1billion

ABPI, 9 March 2016

 

New figures show that the pharmaceutical industry has contributed over £1billion to the Department of Health towards the cost of new medicine as part of the voluntary Pharmaceutical Repayment Regulation Scheme. The scheme is designed to make new treatment affordable and accessible to the NHS.

 

 

Revealed: The pharmacies ready to take government to court

C&D, Samuel Horti, 9 March 2016

 

Law firm Charles Russel Speechlys has revealed the names of five pharmacies who are threatening to take the government to court over funding cuts. These are Hopkins Pharmacy, Hobbs Pharmacy, Medipharmacy Group, CG Murray’s Pharmacy and Kamsons Pharmacy. Three of the law firm’s eight clients remain anonymous.

 

 

Parliamentary Coverage

 

There is no Parliamentary coverage today.

 

Full Coverage

Pharmaceutical industry’s contribution towards NHS medicines bill hits £1billion

ABPI, 9 March 2016

 

New figures out today from the Association of the British Pharmaceutical Industry, show that the pharmaceutical industry has contributed over £1billion to the Department of Health towards the cost of new medicines as part of the voluntary Pharmaceutical Payment Regulation Scheme (PPRS).

 

The scheme is intended to help make the latest treatments affordable for NHS patients and give UK patients the same level of access to new medicines as other EU countries.

 

The figures also show that the NHS spend on branded medicines that is covered under the PPRS scheme is essentially flat; from £2,136million in 2014/15 to £2,146 million in 2015/16.

 

Despite industry funding, new medicines approved as clinically and cost effective by NICE are not always being adopted and used by the NHS locally.

 

The pharmaceutical industry has been committed to improving the flow of new medicines into the NHS. Over the five years of the PPRS scheme the industry expects to contribute over £3billion to the Department of Health.

 

Richard Torbett, Executive Director Commercial at ABPI, said: “Since 2014 our members have paid over £1billion towards a scheme that they hoped would improve the flow of new medicines into the NHS patients, allowing patients to get access to treatments that are widely available in other European countries.

 

“This current PPRS scheme runs for five years and offers an important opportunity to ensure more NHS patients can benefit from NICE approved medicines. To ensure we are making the most of this opportunity, we need to sit down with colleagues in the Department of Health and the NHS and establish how to remove barriers, which are currently preventing the NHS from effectively rolling out the use of these new treatments.

 

“We hope that the Government’s independent Accelerated Access Review – which aims to speed up the use of transformative medicines in the NHS – will provide an opportunity to address some of these issues.”

HDA Media And Political Bulletin – 10 March 2016

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?